Abivax ABVX
NASDAQ ABVX
$91.44 +1.44 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Abivax (ABVX) Other financing activities (as filed) (2024 - 2026)

Updated

Abivax (ABVX) posted Other financing activities (as filed) of -$753,210 for Q2 2026, compared with -$541,077 a year earlier.

Analysis

Abivax (ABVX) Other financing activities (as filed) (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other financing activities (as filed) at Abivax was -$931,429; for FY2025, it came in at -$690,315.

  • In prior years, Abivax's Other financing activities (as filed) was -$230,538 in FY2024, -$395,909 in FY2023, -$314,079 in FY2022 and -$5.21 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Other financing activities (as filed) in data going back to Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Abivax 7.07 Bn 4.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -274,317.40
Mar 31, 2026 -482,347.21
Dec 31, 2025 -150,161.61
Sep 30, 2025 -28,057.32
Jun 30, 2025 -541,076.73
Mar 31, 2025 21,037.69
Dec 31, 2024 -58,772.75
Sep 30, 2024 -137,277.44
Jun 30, 2024 115,226.97
Mar 31, 2024 -152,090.65
API Access

Abivax Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ABVX&period=max&api_key=YOUR_API_KEY